ANGUSTA cpr 25 mcg 8 pce
7680675800018
CH-67580
G02AD06
09.01.1.
Active substances:
Reimbursement limitations:
AUGMENTIN
Administration parentérale seulement pour patients, qui ne peuvent pas prendre des médicaments par voie orale.
1 / 3
google
Details
- Product number
- 6758001
- CPT
- -
- Packaging group
- 8
- Unit
- Tablette(n)
- Composition
- misoprostolum 0.025 mg, hypromellosum, cellulosum microcristallinum, maydis amylum, carmellosum natricum conexum corresp. natrium 0.87 mg, crospovidonum, silica colloidalis anhydrica, pro compresso.
Articles (1)
Angusta 25 ug, Tabletten
Tabletten
8
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
misoprostolum
|
0.025 MG | Substance | Wirkstoff (Principe actif) |
|
hypromellosum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.87 MG | Substance | HBESI |
|
crospovidonum
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
Authorization holder
Norgine AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 67580
- Drug name
- Angusta, Tabletten
- Galenic form
- TAB
- ATC Code
- G02AD06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 10/01/2022
- Authorization expiration date
- 31/12/9999
- IT number
- 09.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANGUSTA cpr 25 mcg 8 pce
- Description (DE)
- ANGUSTA Tabl 25 mcg 8 Stk
- Market launch
- 10/01/2022
- Narcotic (BTM)
- No